Articles

Indiana could weather U.S. default for a couple months

The state would be able to draw down its $1.2 billion cash reserves and lean on money from the $3.8 billion Indiana Toll Road lease to carry it for a few months until the federal government came up with a plan, according to Budget Director Adam Horst.

Read More

Indiana life sciences leaders look toward the future

Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue’s Discovery Park.

Read More

More life sciences firms opt to launch products in Europe

The U.S. Food and Drug Administration’s growing reputation for unpredictability is spurring some Indianapolis companies to join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations occurring in their backyards.

Read More